HomeSFOSF • OTCMKTS
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Nakaraang pagsara
$1.95
Sakop ng taon
$1.50 - $2.24
Market cap
61.17B HKD
Average na Volume
24.00
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 10.16B | -5.09% |
Gastos sa pagpapatakbo | 4.25B | -14.46% |
Net na kita | 759.24M | 635.70% |
Net profit margin | 7.48 | 679.17% |
Kita sa bawat share | — | — |
EBITDA | 1.00B | 115.25% |
Aktuwal na % ng binabayarang buwis | 9.46% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 16.12B | 3.45% |
Kabuuang asset | 117.46B | 3.52% |
Kabuuang sagutin | 57.53B | 1.18% |
Kabuuang equity | 59.93B | — |
Natitirang share | 2.66B | — |
Presyo para makapag-book | 0.11 | — |
Return on assets | 0.79% | — |
Return on capital | 0.96% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 759.24M | 635.70% |
Cash mula sa mga operasyon | 1.49B | 56.45% |
Cash mula sa pag-invest | -1.17B | -119.37% |
Cash mula sa financing | -500.30M | 46.76% |
Net change in cash | -85.94M | 85.18% |
Malayang cash flow | 2.92B | 9.19% |
Tungkol
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Itinatag
1994
Website
Mga Empleyado
40,557
